glp 1 and sleep apnea Episode 75- drugs GLP-1 therapies reduce OSA risk

Key pancreatic markers: Both amylase and lipase can rise modestly on GLP-1 medications without indicating pancreatitis this is a known pharmacological effect

But fair warning: Bozos like David Sinclair, who has repeatedly been called out by his peers for overstating if not fabricating clinical results of longevity research, are also behind glossy, overly optimistic reviews of Metformin, like this one

Meta-analyses of clinical trials show that GLP-1 RAs, particularly semaglutide, lead to moderate but clinically meaningful reductions in body weight among adolescents with obesity

p -value 0.3462]), and semaglutide (RR 1.9181 [95% CI 0.2354, 7.8184

Key players in the biosimilars market include Sandoz Group AG (Switzerland), Pfizer Inc